Obe-cel in Adult ALL - The Felix Study
The Felix Study
The FELIX study is our phase 2 clinical trial designed to evaluate our obe-cel product in patients with relapsed/refractory adult B-cell acute lymphoblastic leukemia.
The FELIX study is currently recruiting in locations across the US, UK and Spain. For further information on this study please follow this link NCT04404660 or to speak to a doctor conducting this study in your area please contact us on [email protected].
For more information on the FELIX study click here. We suggest that you discuss this information with your doctor (healthcare provider) to understand the available options open to you.
Additional information on the FELIX study can also be found on the Cancer Research UK Felix Study.